Therapy
Health
Pharmaceutical

TherapeuticsMD

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (3.25%) Today
+$0.06 (2.04%) After Hours

Why Robinhood?

You can buy or sell TherapeuticsMD and other stocks, options, ETFs, and crypto commission-free!

About

TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. Read More The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Employees
241
Headquarters
Boca Raton, Florida
Founded
1907
Market Cap
767.09M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
3.04M
High Today
$3.32
Low Today
$3.10
Open Price
$3.10
Volume
1.31M
52 Week High
$7.66
52 Week Low
$3.00

Collections

Therapy
Health
Pharmaceutical
Healthcare
Manufacturing
Technology
US
North America

News

Yahoo FinanceMay 9

Edited Transcript of TXMD earnings conference call or presentation 6-May-19 8:30pm GMT

Q1 2019 TherapeuticsMD Inc Earnings Call Beverly Hills May 10, 2019 (Thomson StreetEvents) -- Edited Transcript of TherapeuticsMD Inc earnings conference call or presentation Monday, May 6, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Daniel Alan Cartwright TherapeuticsMD, Inc. - CFO & Treasurer * Dawn Halkuff ...

314
Yahoo FinanceMay 8

TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (TXMD), an innovative, leading women’s healthcare company, today announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference. Chief Executive Officer Robert G. Finizio will provide an overview of the company at the conference. Details for the presentation include: Conference Bank of America Merrill Lynch 2019 Health Care Conference Date Wednesday, May 15, 2019 Time 5:15 p.m. PT A live webcast and re...

470
NasdaqMay 7

Here's Why TherapeuticsMD Fell as Much as 17.6% Today

1,063

Earnings

-$0.21
-$0.16
-$0.12
-$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 30, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.